Clinical Trials Logo

Clinical Trial Summary

Researchers are trying to determine the efficacy of a global metabolomic approach in testing for and diagnosing inborn errors of metabolism as opposed to traditional testing methods.


Clinical Trial Description

Residual samples will be tested for a variety of biomarkers that may lead to better understanding of these disorders and help develop treatment options. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04201067
Study type Observational
Source Mayo Clinic
Contact
Status Enrolling by invitation
Phase
Start date October 8, 2019
Completion date August 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04199000 - Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
Completed NCT03250728 - Role of the Endothelium in Stroke-like Episode Among CDG Patients N/A
Recruiting NCT02089789 - Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Completed NCT02955264 - Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation N/A
Completed NCT03560570 - Study of Hemostasis in Patients With Congenital Disorder of Glycosylation